Thuja invests in private healthcare companies in the space of biotech, nutraceuticals, medtech and digital health.
Location: Netherlands, Utrecht
Investors 2
| Date | Name | Website |
| - | Delft Ente... | delftenter... |
| - | Utrecht Ho... | utrechthol... |
Mentions in press and media 10
| Date | Title | Description |
| 26.02.2026 | ATRO Medical: €3 Million Raised To Advance Artificial Meniscus Toward Pivotal Studies | ATRO Medical, a Netherlands-based clinical-stage orthopedic medical device company, has secured €3 million in a new financing round to advance development of its Artimis Meniscus Prosthesis, an artificial meniscus implant designed for patie... |
| 13.12.2025 | Pan Cancer T: €10 Million Funding Raised To Launch In-Human Trial Of TCR-T Cell Therapy For Triple-Negative Breast Cancer | Pan Cancer T, a Rotterdam-based biotech developing next-generation T cell therapies for solid tumours, has raised €10 million to move its lead program, PCT1:CO-STIM, into a first-in-human clinical trial for women with triple-negative breast... |
| 29.05.2025 | Salvia BioElectronics: A New Dawn for Migraine Sufferers | In the world of chronic pain, migraines reign supreme. They are not just headaches; they are life-altering storms that can sweep away productivity, joy, and social connections. For millions, the search for relief is a relentless journey. En... |
| 27.05.2025 | Migraines? This Dutch startup just raised €53 million to transform migraine treatment with its ultra-thin implant | Eindhoven-based Salvia BioElectronics, a clinical-stage medical device company innovating neuromodulation therapy for patients with chronic migraine, today announced the successful completion of their €53 million Series B financing round. T... |
| 10.11.2023 | Artica Therapeutics Closes €12M Seed Investment to Develop Covalent Therapeutics for Autoimmune and Inflammatory Disorders. | Leiden, The Netherlands. 2 November, 2023. Artica Therapeutics B.V. (Artica), a biotechnology company unlocking the power of medicines with insurmountable binding characteristics, today announced it has raised €12 million in Seed financing.... |
| 08.09.2023 | France-based Gradient Denervation Technologies bag €14M to develop novel pulmonary hypertension therapy | Read this article in: France-based medtech startup Gradient Denervation Technologies announced on Thursday that it had raised €14M in a Series A round of funding. Asabys Partners led the financing effort through its newly established fund, ... |
| 07.09.2023 | Gradient Denervation Technologies cierra una serie A de €14m liderada por Sabadell Asabys | 07/09/2023 Nota de prensa GRADIENT DENERVATION TECHNOLOGIES CIERRA UNA SERIE A DE €14M LIDERADA POR SABADELL ASABYS Gradient Denervation Technologies (“Gradient”), una empresa de dispositivos médicos que desarrolla una solución innovador... |
| 18.11.2022 | FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant | November 17, 2022 |
| 21.12.2021 | Amgen's Otezla bags expanded FDA nod in psoriasis; I-Mab CEO hits the exit amid shakeup at Chinese firm | Just a few weeks after Otezla notched a Phase III win and hit all primary and secondary endpoints for a trial in genital psoriasis, Amgen’s blockbuster drug Otezla gets yet another OK from the FDA. The biotech announced ye... |
| 13.06.2016 | Medtech Venture Capital Firm Thuja Capital Management Launches €34M Fund | Utrecht, The Netherlands-based Thuja Capital Management has launched a new €34m venture capital fund. Thuja Capital Healthcare Fund II (TCHF II) will invest in products improving diagnosis, cure or care, and contributing to lowering the cos... |